<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-11T23:18:15+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>RNAi疗法：走出至暗时刻，全新时代已来</title>
    <updated>2020-12-11T20:59:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/ZXsEl_S8UwMibxEEQdJPrw</id>
    <link href="https://mp.weixin.qq.com/s/ZXsEl_S8UwMibxEEQdJPrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>收购PROTAC公司之后，Roivant的蛋白降解剂开发平台又获2亿美元投资</title>
    <updated>2020-12-10T21:00:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/9KkYkFp7gueHchXqMqnDQw</id>
    <link href="https://mp.weixin.qq.com/s/9KkYkFp7gueHchXqMqnDQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新一代癌症免疫疗法「ISAC」来了：实现肿瘤完全消退，临床试验进行中 | Nature子刊</title>
    <updated>2020-12-09T21:01:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/p1F0MsVweE3XgXfJrIzUCw</id>
    <link href="https://mp.weixin.qq.com/s/p1F0MsVweE3XgXfJrIzUCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿尔茨海默症新靶点通路——Drp1-HK1-NLRP3</title>
    <updated>2020-12-08T20:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/2ueCSJ36_0I1mXR00Cy6ew</id>
    <link href="https://mp.weixin.qq.com/s/2ueCSJ36_0I1mXR00Cy6ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊揭秘：抑制肿瘤复发的秘密武器——β受体阻滞剂</title>
    <updated>2020-12-07T21:00:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/0pVEB-jVa2tFf57ucZ7ukQ</id>
    <link href="https://mp.weixin.qq.com/s/0pVEB-jVa2tFf57ucZ7ukQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国科学家开发新型CAR-T疗法：恶性脑瘤小鼠模型中完全缓解率达60% | Science子刊</title>
    <updated>2020-12-06T21:06:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/QIB77H-1C_yjNDgf4MwKbA</id>
    <link href="https://mp.weixin.qq.com/s/QIB77H-1C_yjNDgf4MwKbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>蛋白降解剂成大热门！艾伯维宣布超10亿美元合作，这次目标是癌症和免疫疾病</title>
    <updated>2020-12-05T21:00:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/ZoI5PzbXC9vFfIbJHV_KcQ</id>
    <link href="https://mp.weixin.qq.com/s/ZoI5PzbXC9vFfIbJHV_KcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制药巨头扎堆，外泌体赛道火热 | Nature子刊最新报告</title>
    <updated>2020-12-04T21:03:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/MnLl-qXHb1eK1qagyeVRNA</id>
    <link href="https://mp.weixin.qq.com/s/MnLl-qXHb1eK1qagyeVRNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature封面：抗衰老突破！基因疗法逆转表观遗传时钟，恢复小鼠视力</title>
    <updated>2020-12-03T21:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/aPKwojimD3CgqBF5IJOH4A</id>
    <link href="https://mp.weixin.qq.com/s/aPKwojimD3CgqBF5IJOH4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T疗法新搭档——PAK4抑制剂</title>
    <updated>2020-12-02T21:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/d7jqi31fSc0ndFsbN80-dA</id>
    <link href="https://mp.weixin.qq.com/s/d7jqi31fSc0ndFsbN80-dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>